1560 related articles for article (PubMed ID: 24895301)
1. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
2. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
4. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
5. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
6. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
[TBL] [Abstract][Full Text] [Related]
8. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
9. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
Yue B; Yang Q; Xu J; Lu Z
Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
[TBL] [Abstract][Full Text] [Related]
11. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
Moubasher AE; Youssef EM; Abou-Taleb DA
Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
[TBL] [Abstract][Full Text] [Related]
12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
13. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
14. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
[TBL] [Abstract][Full Text] [Related]
17. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
[TBL] [Abstract][Full Text] [Related]
18. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
Vachiramon V; Sahawatwong S; Sirithanabadeekul P
Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
[TBL] [Abstract][Full Text] [Related]
19. A randomized, split-face clinical trial of Q-switched alexandrite laser versus Q-switched Nd:YAG laser in the treatment of bilateral nevus of Ota.
Wen X; Li Y; Jiang X
J Cosmet Laser Ther; 2016; 18(1):12-5. PubMed ID: 25968166
[TBL] [Abstract][Full Text] [Related]
20. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
